Current perspectives on statins

Journal of the Indian Medical Association

Volumn 101, Issue 6, 2003, Pages 381-383

  Mishra, Trinath Kumar ^a   Routray, Satyanarayan ^a  

^a SCB MEDICAL COLLEGE   (India)

Author keywords

Coronary artery disease; Statin; Study; Trial

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA TOCOPHEROL; ASCORBIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CHOLESTEROL; COLESTYRAMINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MEVINOLIN; PLACEBO; PRAVASTATIN; SIMVASTATIN; STATIN;

CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DRUG INDICATION; DRUG SAFETY; HIGH RISK POPULATION; HUMAN; INDIA; PREVENTIVE MEDICINE; PRIMARY PREVENTION; REVIEW; RISK MANAGEMENT; SECONDARY PREVENTION;

EID: 0141929259     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (10)

1. Gupta R, Gupta VP - Meta-analysis of coronary heart disease prevalence in India. Indian Heart J 1996; 48: 241-5.
2. Kumar S, Das MK - Malignant coronary artery disease in Indians. In: Dasgupta RD, Kumar S, editors. Current Trends in Cardiology. 1st ed. Kolkata: Vivekananda Institute of Medical Sciences, 2001: 27-41.
3. Gopinath N, Chadha SL, Sehgal A, Shekhawat S, Tandon R - What is 'desirable' lipid profile. Indian Heart J 1994; 46: 325-7.
4. Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al - For the AFCAPS/TexCAPS Research group. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS. JAMA 1998; 279: 1615-22.
5. Sacks FM, Pfeffer MA, Moya LA, Rouleau JL, Rutherford JD, Cole TG, et al - The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels: Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996; 335: 1001-9.
6. Heart Protection Study Collaborative Group - MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high risk individuals: a randomised placebo - controlled trial. Lancet 2002; 360: 7-21.
7. Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, et al - Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995; 333: 1301-7.
8. Rosenson RS, Tangney CC - Antiatherothrombotic properties of statins: implications for cardiovascular event reduction. JAMA 1998; 279: 1643-50.
9. The Long-term Intervention with Pravastatin in Ischemic Disease (LIPID) study group - Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Eng J Med 1998; 339: 1349-57.
10. Scandinavian Simvastatin Survival Study Group - Randomized trial of cholesterol lowering in 4444 participants with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994; 344: 1383-9.